Search Tag: Molecular Diagnostics
2023 10 Jul
Inflammatix, a pioneering molecular diagnostics company, announced the appointment of Heiner Dreismann, PhD, as a member of the company's board of directors. Inflammatix appoints former Roche Molecular Systems CEO Heiner Dreismann, PhD, to its Board of Directors. Dr. Dreismann brings to Inflammatix more than 35 years of experience in the life...Read more